Finance

Explore the landscape of Finance in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Finance to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

AnnJi Advances AJ201 into Pivotal Phase 3 ROMA‑KD Trial – The Only Investigational Therapy for SBMA in Late‑Stage Development Worldwide
CompanyDrug

AnnJi Advances AJ201 into Pivotal Phase 3 ROMA‑KD Trial – The Only Investigational Therapy for SBMA in Late‑Stage Development Worldwide

AnnJi Pharmaceutical Co., Ltd. (TPEx: 7754), a clinical‑stage drug development company focused on innovative small molecules, announced that it is proceeding with the U.S. portion of its pivotal Phase 3…

Asymchem's Tianjin Macromolecule Site Passes First FDA Pre‑Approval Inspection – EIR Issued for Commercial API Facility

Asymchem’s Tianjin Macromolecule Site Passes First FDA Pre‑Approval Inspection – EIR Issued for Commercial API Facility

Pfizer's Oral Ritlecitinib Meets Primary Endpoints in Phase III Nonsegmental Vitiligo Trials – Largest‑Ever Oral Systemic Program Clears Path for Global Filings

Pfizer’s Oral Ritlecitinib Meets Primary Endpoints in Phase III Nonsegmental Vitiligo Trials – Largest‑Ever Oral Systemic Program Clears Path for Global Filings

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Company

Sandoz Reports H1 2023 Financials with 8% YOY Growth, Separation from Novartis Looms

CompanyDeals

Pilot Gene Technology Secures $13.8 Million in Series B Financing for Diagnostic Expansion

CompanyDeals

Innovac Therapeutics Secures $18 Million in Pre-Series A Financing for mRNA Vaccine Development

Company

Johnson & Johnson Reports H1 2023 Sales Growth Following Kenvue Spinoff

CompanyDeals

Ronovo Surgical Secures Pre-Series B+ Funding to Advance Modular Surgical Robots

CompanyDeals

Kangpu Biopharmaceuticals Secures Series B Funding to Advance Molecular Glue Therapies

CompanyDeals

Epigenic Therapeutics Secures $32 Million in Series A Funding for Gene Modulation Therapy

CompanyDeals

Sandoz Expands Anti-Infective Portfolio with Acquisition of Astellas Pharma’s Antifungal Mycamine

Show More